Radcliffe Capital Management’s HealthCor Catalio Acquisition Corp. Class A Ordinary Shares HCAQ Stock Holding History

Radcliffe Capital Management’s Portfolio HCAQ Stock Details HCAQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200,000	Closed	-$1.98M	–	1146
2021 Q3	$1.98M	Hold	200,000	–	–	0.06%	466
2021 Q2	$1.97M	Hold	200,000	–	–	0.06%	505
2021 Q1	$2M	Buy	+200,000	New	+$2.05M	0.08%	423

Radcliffe Capital Management's HCAQ Position: Q4 2021 in Review

Radcliffe Capital Management sold out of HealthCor Catalio Acquisition Corp. Class A Ordinary Shares (HCAQ) in Q4 2021, closing a stake of 200,000 shares — an estimated $1.98M sold.

Radcliffe Capital Management first reported a position in HCAQ in Q1 2021 and held it in 3 quarters. The position peaked at $2M in Q1 2021. 0 funds tracked by Wall St. Rank hold HCAQ as of Q4 2021.

Radcliffe Capital Management reported no remaining HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
Radcliffe Capital Management sold 200,000 HealthCor Catalio Acquisition Corp. Class A Ordinary Shares shares in Q4 2021, an estimated $1.98M.
Radcliffe Capital Management first reported a position in HealthCor Catalio Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 3 quarters.
Radcliffe Capital Management's HealthCor Catalio Acquisition Corp. Class A Ordinary Shares position peaked at $2M in Q1 2021.
0 funds tracked by Wall St. Rank held HealthCor Catalio Acquisition Corp. Class A Ordinary Shares as of Q4 2021.

Based on Radcliffe Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.